As May Marks Cancer Research Awareness Month, Kate Amato Foundation Receives $50,000 Donation from Experian Health to Support Pediatric Cancer Research

$50,000 check from Experian
Experian Healthcare presents Kate Amato Foundation with a $50,000 donation. Pictured, from left to right: Ross Hart, Jeff Amato, Lisa Amato and Ben Kern.

Kate Amato Foundation (KAF) is thrilled to announce that it recently received a generous donation of $50,000 from Experian Health, a segment of Experian, a global data and technology company. This significant contribution will prove instrumental in funding innovative pediatric cancer research at leading facilities across the country.

KAF will utilize this donation to develop safer, smarter, and more effective treatments for children battling cancer. As May marks Cancer Research Awareness Month (#NCRM24), it’s imperative to recognize that pediatric cancer remains the leading cause of death by disease in children. Despite this grim reality, only 4% of total federal research funding is allocated to childhood cancers. Additionally, the pharmaceutical industry’s reluctance to invest in pediatric cancer research, citing the larger and more profitable adult cancer market, highlights the dire need for initiatives like this. Deeming childhood cancer research ‘not a good investment’ only perpetuates the cycle of underfunding and limited treatment options for young patients. Donations and partnerships like the one with Experian are not just impactful but essential in advancing progress and ultimately saving young lives.

“We are celebrating this partnership with Experian because it is a beacon of hope. Corporate alliances and generous benefactors are vital for advancing the pace of progress for all our children,” said Lisa Amato, co-founder of the Kate Amato Foundation. “Considering the staggering reality that Americans spend more on Starbucks in three days than we invest in pediatric cancer research in an entire year, the urgency is undeniable. This partnership marks a pivotal step towards brighter futures for children battling cancer.”


The inspiration behind Kate Amato Foundation stems from the heartbreaking loss of Kate Amato, Lisa and Jeff’s daughter, who bravely fought cancer for two and a half years until she lost her battle in November of 2016 at only 11 years old. Witnessing the inadequacies of outdated treatments and the severe underfunding of pediatric cancer firsthand, Lisa and Jeff established the foundation to honor Kate’s memory and continue the fight for other children.

Over the years, KAF has made significant strides in funding cutting-edge pediatric cancer research projects at leading institutions across the country, including Duke University, Texas Children’s Cancer Center/Baylor College of Medicine, Children’s Hospital of Philadelphia (CHOP), and Dana-Farber Cancer Institute/Harvard Medical School. To date, the foundation has awarded $575,000 in grants to support revolutionary research projects to save young lives.


The foundation’s funding is fueled by the generosity and support of businesses and donors and through their signature KATE events, including the KATE KUP Triples Tennis Tournament, KATE KOMBO Golf and Pickleball Tournament and Kate’s Kindness Project. Many individuals first learn of the foundation and their mission through these annual events. Benjamin Kern, Experian’s Sales Leader for Growth, attended the first annual KATE KOMBO in October of 2023.

Experian Health services more than 60 percent of U.S. hospitals and over 7,500 medical practices, labs, pharmacies, and other healthcare providers with data and technology that simplifies healthcare.
Kate Amato Foundation is optimistic about the relationship with Experian Health, anticipating that their shared vision and collaborative efforts will pave the way for transformative advancements in pediatric cancer research and bring renewed optimism to countless young lives. Their hope is that this is the beginning of a long and fruitful partnership and that other companies, as well as generous individual donors, will follow the lead of Experian Health and join the battle against childhood cancer. This funding will provide what is desperately needed to develop more effective treatments for children suffering from this disease.

Posted in